Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TIE2/TEK is a critical endothelial-specific receptor tyrosine kinase mediating responses to angiopoietins. It orchestrates blood vessel stabilization during development but also plays key roles in disease-related neovascularization. Its unique structure enables specific ligand interactions that regulate downstream signaling essential for vascular health—and makes it an attractive target for therapies aimed at controlling abnormal blood vessel growth in cancer and other pathologies.
Inhibition of Angiopoietin-TIE2 interaction to prevent pathological angiogenesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Angiopoietin Receptor TIE2 (TIE2).